Showing results (1-10 of 356) with videos related to
Sort By:
Pageof 36
Rambam Maimonides Medical Journal|September 24, 2019
Too Many Avoidable Suicides Occur Worldwide in Young PatientsKlaus Rose, David Neubauer, Jane M Grant-KelsCurrent Therapeutic Research, Clinical and Experimental|August 8, 2019
Questionable Industry-Sponsored Postneonatal Pediatric Studies in SloveniaKlaus Rose, David Neubauer, Jane M Grant-KelsRambam Maimonides Medical Journal|July 24, 2019
Rational Use of Medicine in Children-The Conflict of Interests Story. A ReviewKlaus Rose, David Neubauer, Jane M Grant-KelsTherapeutic Innovation & Regulatory Science|December 12, 2018
The Meanings of "Pediatric Drug Development"Klaus Rose, Jane M Grant-KelsChildren (Basel, Switzerland)|March 21, 2018
Pediatric Melanoma and Drug DevelopmentKlaus Rose, Jane M Grant-KelsRambam Maimonides Medical Journal|March 29, 2021
COVID-19 and Treatment and Immunization of Children-The Time to Redefine Pediatric Age Groups is HereKlaus Rose, Jane M Grant-Kels, Earl B Ettienne, et al.Journal of Law and Medicine|June 5, 2023
"Pediatric" Drug Studies Might Be the Largest Abuse in Medical Research in History. It Is Time for Lawyers to Step InKlaus Rose, Jane M Grant-Kels, Pasquale Striano, et al.Expert Review of Neurotherapeutics|February 25, 2022
Neurology's vital role in preventing unnecessary and potentially harmful pediatric studiesKlaus Rose, Earl B Ettienne, Jane M Grant-Kels, et al.Expert Opinion on Pharmacotherapy|March 4, 2025
Melanoma and pediatric drug development: clinical progress vs. regulatory activism in minors - a narrative reviewEarl B Ettienne, Jane M Grant-Kels, Pasquale Striano, et al.Expert Opinion on Pharmacotherapy|September 13, 2024
Pharmacogenomics and pediatric drug development: science and political power. A narrative reviewEarl B Ettienne, Jane M Grant-Kels, Pasquale Striano, et al.Pageof 36